Join the Temozolomide group to help and get support from people like you.
Temozolomide News
Updated Recommendations Issued for Management of Grade 4 Diffuse Glioma
TUESDAY, July 8, 2025 – In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 25 in Practical Radiation Oncology, updated recommendations...
FDA Approves New and Updated Indications for Temozolomide Under Project Renewal
On September 14, 2023, the Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence (OCE) initiative...